Thanks for drawing attention to this again Pharma - it points to an interesting development. The one query I have however is if the company wants shareholders to grasp its significance why is the announcement written in gobbledygook? Blinded by science is fine, but not to your shareholders surely.
Keep up the work!
- Forums
- ASX - By Stock
- Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
Thanks for drawing attention to this again Pharma - it points to...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable